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Summary
Background—Delay in presentation to a health facility is an important concern for TB control.
The effect of stigma on delay in seeking care for TB symptoms is not well studied, especially in the
context of the HIV co-epidemic.
Objective—To estimate the association of TB and AIDS stigma on delay in seeking care for TB
symptoms.
Setting/Design—For 480 newly diagnosed patients with TB, time from first TB symptom to the
first visit to a qualified provider was calculated. Stigma scales were administered to each patient to
obtain a stigma score.
Results—Among men, those with higher TB stigma had a small increase in delay times, while
women had a small decrease in delay. Among patients presenting with hemoptysis, higher TB stigma
was associated with a small increase in delay, while among patients presenting with fever or
extrapulmonary symptoms only, higher TB and AIDS stigma resulted in shorter delay times.
Conclusion—In a population with a relatively short median delay (26 days), the impact of TB and
AIDS stigma translates into a minimal change in delay time. This suggests that stigma does not have
a clinically relevant effect on TB patient delay in southern Thailand.
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Introduction
From its introduction in 1994, DOTS has been the backbone of tuberculosis (TB) control
around the world. With its focus on passive case detection, availability of diagnostic techniques,
and directly observed therapy to minimize drug resistant TB, DOTS has been criticized as a
treatment guideline and biomedical strategy that does not account for social factors related to
TB control rather than a comprehensive control plan 1, 2. Delay in presentation to a health
facility is an important concern as it contributes to delays in initiating TB treatment. This can
result in greater morbidity and mortality for the patient and increased transmission of
Mycobacterium tuberculosis in the community 3-6.
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There is a large body of literature on factors associated with delay in seeking care for TB
symptoms. These can be broadly grouped into access to care, personal characteristics,
socioeconomic, clinical, TB knowledge or beliefs, and social support or psychosocial factors
7. One psychosocial factor of interest is health-related stigma, often defined as a social process
“characterized by exclusion, rejection, blame, or devaluation resulting from experience or
reasonable anticipation of an adverse social judgment” because of a particular health condition
8. Some studies have suggested that TB stigma could lead to delays in patients seeking
appropriate medical care 9-11. Others note that AIDS stigma and fears of being labeled as an
AIDS patient could deter TB patients from seeking care because of the belief that someone
with TB also has AIDS 12, 13.
Seven studies of delay among patients with TB or cough have included some measurement of
stigma as a covariate. In six of these, stigma was not associated with patient delay in seeking
care for TB symptoms 13-18, including one specifically assessing the relationship between TB
stigma and delay using a modified stigma scale initially developed for AIDS and cancer. A
multi-country study by the World Health Organization (WHO) in the eastern Mediterranean
region reported that increased stigma was associated with decreased patient delay in Somalia
19. No studies, however, have assessed the effect of both TB and AIDS stigma on TB patient
delay using quantitative stigma scales.
Using formally developed stigma scales 20, this study investigated whether higher TB or AIDS
stigma was associated with longer delays in seeking care for TB symptoms in southern
Thailand.
Study Population and Methods
Study participants and data collection
Adults (>17 yrs) with newly diagnosed TB between August 2005 and July 2006 were enrolled
from the regional TB center and seven hospital-based TB clinics in southern Thailand. Patients
were not eligible if they had been receiving TB treatment for more than one month. Information
on demographics, socioeconomic status, access to the first qualified health provider, TB
knowledge, and TB symptoms were collected by trained interviewers using a standardized
questionnaire. Patients were referred for HIV counseling and testing if their status was
unknown or if they had tested negative more than six months prior to enrollment. An HIV test
was not required for participation. Four stigma scales were administered to all participants: TB
stigma from the community perspective (11 items) and patient perspective (12 items) and AIDS
stigma from the community perspective (11 items) and patient perspective (10 items) 20. Items
were scored using a Likert scale with four levels: strongly disagree (0), disagree (1), agree (2),
and strongly agree (3), with higher scores indicating higher stigma. Responses were summed
for each scale to create stigma scores to be used in analysis. Stigma scores were standardized
by dividing the summed score by the number of items in the scale, resulting in a possible range
of 0 to 3. These item-adjusted scores were used to compare scores between scales.
Patient delay, defined as the time between onset of TB-related symptoms and the first visit to
a qualified provider (private or public health clinic or hospital), was the outcome of interest.
Health services delay, defined as the time between first presentation to a provider and diagnosis
of TB, was not considered in this analysis because stigma would not be expected to affect
clinical decisions or diagnostic processes. Upon enrollment in the study, patients were asked
to recall the duration of their symptoms and when the first visit to a qualified provider occurred.
Delay was calculated as the number of days between these two points. Patients who were
asymptomatic were excluded from the analysis. The delay distribution was normalized using
the log10 transformation to satisfy regression assumptions.
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Stigma scores and log-transformed delay were modeled as continuous variables using
multivariable linear regression (SAS 9.1, PROC GENMOD with identity link and normal
distribution). Four analyses were performed using each stigma score as the exposure of interest.
Potential confounders were included in the model based on substantive knowledge and with
the aid of directed acyclic graphs 21, 22. These covariates included age, gender, religion,
education, income, number of children and adults in the household, availability of a friend for
travel to the health provider, travel time to the first qualified provider, mode of travel, TB
knowledge (cause, transmission, and TB/HIV), prior testing for AIDS, HIV status, and TB
symptoms. We considered interactions between stigma and gender, HIV status, and TB
symptoms because it has been suggested that stigma adversely affects women 23 and that AIDS-
related factors may play an important role in both stigma and delay 12, 13. Interactions were
assessed individually using interaction terms in the fully adjusted model. Interactions with
p≤0.20 in at least one model were used in all four models. Regression results are presented as
mean differences in log-transformed delay. Anti-log transformation of the parameter estimates
requires complex bias-correction. However, anti-log transformation of the confidence limits
provides an upper and lower bound for the relative change in delay on the day scale, rather
than the log-day scale, which aids in the interpretation of the results.
Ethics approval
This study was approved by the Institutional Review Boards of the University of North Carolina
and the Prince of Songkla University. Written informed consent was obtained from all patients.
Results
Participant characteristics
Fourteen asymptomatic patients (3%) were excluded from the analysis. An additional 34 (7%)
patients were excluded due to improbable calculations of delay (32 with delay <0 days, two
with delay >600 days). The final sample size was 432 patients. There was very little difference
in exposure and covariate distributions among patients who were included and those excluded
from the analysis, with the exception of mode of transportation (Table 1).
Nearly all patients (97%) knew that TB was curable. Patients primarily attributed their TB to
smoking or drinking (34%), followed by infection from someone else (18%) or having a weak
body (17%). While many reported non-infectious causes, transmission via eating, drinking,
coughing, or sneezing was also reported. Most patients were aware of the link between TB and
HIV.
Most patients experienced cough, with or without hemoptysis (76%). Upon diagnosis of TB,
67 (17%) patients were co-infected with HIV and knew their serostatus. Of the 314 patients
referred for HIV testing, 235 (75%) accepted and 19 new infections were identified for an
overall HIV prevalence of 20%.
Stigma and delay
Stigma scores could not be calculated for 13 (3%) patients due to incomplete item responses
on the TB stigma from the community perspective scale and 16 patients (4%) for each of the
remaining scales. All stigma scores had an approximately normal distribution and mean item-
adjusted scores ranged from 1.65 to 1.97 (Table 1).
Delay was highly skewed and ranged from 1 to 365 days (Figure 1). Median delay was 26 days
with noticeable digit preference. Log10 transformation effectively normalized the delay
distribution. Within categories of covariates, median delay times ranged from 14 days among
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those who presented with fever and/or extrapulmonary disease only, to 30 days among those
who were HIV co-infected and those who presented with hemoptysis. The median delay time
among men was one week longer than among women (28 vs. 21.5 days).
Adjusted results for the effect of stigma on delay are reported in Table 2 as the mean difference
in log-transformed delay per unit increase in the summed stigma score. Results are reported
for all TB patients and then stratified by gender and presenting symptoms. Among all patients
with TB, stigma had no effect on delay with mean differences nearly equal to zero. Among
men, a one unit increase in TB stigma from the community perspective was associated with a
0.012 (95% CI: -0.001, 0.025) increase in log-delay. Similar results were observed for TB
stigma from the patient perspective. AIDS stigma had no effect on delay times among men.
The opposite was observed among women, where those reporting higher TB stigma had a
decrease in log-delay. AIDS stigma from the community perspective was also associated with
a 0.015 (95% CI: -0.032, 0.002) decrease in log-delay among women.
When the effect of stigma on delay was stratified by presenting symptoms, there was no
association between stigma and delay among patients presenting with cough. Patients with
hemoptysis, however, had a 0.022 (95% CI: 0.001, 0.043) increase in log-delay per unit
increase in TB stigma from the community perspective and a 0.035 (95% CI: 0.011, 0.060)
increase for TB stigma from the patient perspective. AIDS stigma from the community
perspective had a slightly smaller association. Among patients with fever or extrapulmonary
symptoms only, both TB stigma scales had an inverse relationship with delay. This also
occurred for AIDS stigma from the community perspective where patients had a 0.034 (95%
CI: -0.069, 0.002) decrease in log-delay per unit increase in stigma.
Similar results were observed when delay was calculated as the time from first cough to the
first visit to a qualified provider (Table 2).
Discussion
This is the first study to use formally developed TB and AIDS stigma scales to estimate the
association between stigma and delay in seeking care for TB symptoms. Overall, we did not
observe any association between TB or AIDS stigma and delay in seeking health care among
individuals who were diagnosed with active TB. However, the estimates differed by gender,
with men reporting higher TB stigma having longer delay times, and women who reported
higher TB stigma having shorter delay times. Qualitative studies have reported that TB stigma
adversely affects women more than men, primarily because of their sensitivity to social
interactions 23. In the context of seeking care for TB symptoms, our findings suggest women
who report higher levels of TB stigma may seek care more quickly in an effort to relieve their
symptoms and minimize any social consequences due to disease.
Among patients with hemoptysis, a symptom highly suggestive of TB, higher TB stigma was
associated with increased delay time, while among patients with fever or extrapulmonary
symptoms only, higher TB and AIDS stigma showed an inverse relationship with delay. It is
interesting to find that among patients with atypical, non-cough symptoms, higher AIDS stigma
from the community perspective was associated with shorter delay times. These patients may
seek care in hopes that their symptoms are attributable to TB, rather than AIDS 12.
The actual impact of stigma on increasing or decreasing the delay time may not be large. The
95% confidence interval furthest from the null was for TB stigma from the patient perspective
among those with fever or extrapulmonary disease. Anti-log transformation of this limit
(10 -0.069 = 0.85) indicates that the lower bound for any change in delay per unit increase in
stigma is a 15% decrease. Given the median delay of 26 days in our study population, this
corresponds to a maximum four day decrease in delay time. The impact of stigma would likely
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be greater in populations where median delay times are much longer. Similarly, changes in
stigma by more than one point could have a greater impact on delay. However, further analyses
in the same population found that modifiable, socio-economic, TB knowledge, and HIV-related
factors would only change summed stigma scores by a maximum of two points (Kipp et al.,
submitted).
Only one other study aimed to assess the effect of TB stigma on delay in seeking care for TB
symptoms and did not find any association 18. However, they modified a stigma scale
previously developed for AIDS and cancer and found poor reliability among one of the sub-
scales. Additionally, measurement of delay had important limitations. All patients received at
least three months of treatment before enrollment and delay was only collected in four week
intervals.
Other studies of delay used a measure of TB stigma as one of many predictor variables. These
included informal measures of stigma such as feeling ostracized 14, a single question about
whether TB is stigmatizing or not 15, 16, and multi-item measures of stigma that were
categorized for analysis 13, 17. Among these, only feeling ostracized was associated with
increased delay 14. A multi-country study of delay found that high stigma was associated with
decreased delay in Somalia 19. However, the scale that was used may not have been a valid
measure of stigma because it included questions on the economic cost of illness and incorrect
knowledge about the biologic effect on female reproductive outcomes and breastfeeding. While
it is often suggested that poor TB knowledge causes higher stigma 24, 25, the evidence for this
is not conclusive, with many studies showing no relationship between TB knowledge and
stigma 26-28. Therefore, poor TB knowledge should not be confused with, or used to assess,
TB stigma.
Some limitations of our study should be acknowledged. Stigma was assessed only after patients
presented at the TB clinics, concurrently with delay time calculation. The levels of stigma
observed may not accurately capture the level of stigma near the time of symptom onset if
stigma changes over time. Additionally, selection bias may have occurred because we only
enrolled patients who presented at TB clinics. We expect this bias to be minimal. In order for
our results to be biased towards the null, the effect of stigma would have to be many times
stronger among those who never presented, which seems unlikely. And because our results are
already small in magnitude, bias away from the null is unlikely. It is also possible that some
recall error occurred. Finally, information on smoking was not collected in this study. While
smoking is thought to be a cause of delay because smokers may mistakenly attribute their cough
to smoking 29, 30, we do not expect this to bias our findings because smoking is unlikely to be
associated with TB or AIDS stigma.
Conclusions
This was the first study to estimate the association of both TB and AIDS stigma on delay in
seeking care for TB symptoms using formally developed stigma scales. Among all patients,
no effect of stigma on delay time was observed. Stigma did have differential results within
gender and presenting symptoms, likely contributing to the overall null effect. Nevertheless,
in this population with a median delay of 26 days, the impact of stigma translates into a minimal
change in delay time. This suggests that stigma may not have a clinically important effect on
TB patient delay in southern Thailand.
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Kernel-smoothed distribution of untransformed delay time.
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TB stigma (Item-adjusted score) Community perspective (mean, SD) 1.67 (0.45) 1.73 (0.41)
Patient perspective (mean, SD) 1.65 (0.37) 1.70 (0.36)
AIDS stigma (Item-adjusted score) Community perspective (mean, SD) 1.69 (0.47) 1.71 (0.47)
Patient perspective (mean, SD) 1.97 (0.36) 2.00 (0.32)
Age Age in years (median, range) 37 (18-79) 36 (18-73)
Income Thousand Baht per month (median, range) 10 (0-90) 12 (0-52)
Household members Children (<15 years old) (median, range) 1 (0-8) 1 (0-8)
Adults (median, range) 3 (0-9) 3 (1-10)
Travel time to provider Minutes to qualified provider (median, range) 20 (5-120) 25 (5-120)
Categorical characteristics N (%) N (%)
Gender Male 284 (65.7) 33 (68.8)
Female 148 (34.3) 15 (31.3)
Religion Buddhist 286 (66.2) 33 (68.8)
Muslim 144 (33.3) 15 (31.3)
Education Less than primary school 143 (33.1) 17 (35.4)
Completed primary 174 (40.3) 17 (35.4)
Completed secondary 115 (26.6) 14 (29.2)
Friend to see doctor with Yes 398 (92.1) 46 (95.8)
No 34 (7.9) 2 (4.2)
Mode of transportation Car/Motorcycle 338 (78.2) 35 (72.9)
Bus 69 (16.0) 13 (27.1)
Walk, Bicycle, Other 25 (5.8) 0 (0.0)
TB knowledge* (Cause) Infected from family/others 78 (18.1) 9 (18.8)
Work hard 64 (14.8) 7 (14.6)
Smoking/drinking 146 (33.8) 16 (33.3)
Heredity 18 (4.2) 2 (4.2)
Weak body 75 (17.4) 7 (14.6)
Eat or drink with patient 17 (3.9) 3 (6.3)
Other 34 (7.9) 4 (8.3)
TB knowledge† (Transmission) Eat/drink with patient 263 (60.9) 28 (58.3)
Cough/sneeze 357 (82.6) 39 (81.3)
Other (touch, sex, other) 113 (26.2) 15 (31.3)
TB knowledge (Cure) Yes 418 (96.8) 45 (93.8)

















No 14 (3.2) 3 (6.3)
TB knowledge† (TB/HIV) TB increases chance of AIDS 221 (51.2) 21 (43.8)
AIDS increases chance of TB 310 (71.8) 36 (75.0)
Symptoms appear similar 305 (70.6) 34 (70.8)
Ever tested for AIDS Yes 184 (42.6) 24 (50.0)
No 248 (57.4) 24 (50.0)
HIV status‡ Negative 266 (61.6) 29 (60.4)
New positive 19 (4.4) 2 (4.2)
Known positive 67 (15.5) 6 (12.5)
Refused test 80 (18.5) 11 (22.9)
TB symptoms§ Cough 221 (51.2) 17 (35.4)
Hemoptysis 105 (24.3) 11 (22.9)
Weight loss 55 (12.7) 4 (8.3)
Fever and/or extrapulmonary only 51 (11.8) 2 (4.2)






Known positives had previously tested positive for HIV infection; New positives identified when diagnosed with
§
Cough and hemoptysis may include other symptoms; Weight loss excludes cough but may include other symptoms
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